The new US President Donald Trump suffered a major defeat on Friday, as his flagship legislation to repeal Affordable Care Act, what is commonly referred to as Obamacare, failed to gain sufficient support.
As the result, the Republican House of Representatives bill on healthcare reform has been withdrawn, casting doubt on the President’s ability to get Republicans to back his other legislative goals such as tax reforms and infrastructure spending which were pillars of his electoral campaign and actions in his early days in office.
With Friday's legislative collapse, Democratic former President Barack Obama's signature domestic policy achievement, Obamacare remains in place despite seven years of Republican promises to dismantle it.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze